These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21666690)

  • 1. A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties.
    Uldrich AP; Patel O; Cameron G; Pellicci DG; Day EB; Sullivan LC; Kyparissoudis K; Kjer-Nielsen L; Vivian JP; Cao B; Brooks AG; Williams SJ; Illarionov P; Besra GS; Turner SJ; Porcelli SA; McCluskey J; Smyth MJ; Rossjohn J; Godfrey DI
    Nat Immunol; 2011 Jun; 12(7):616-23. PubMed ID: 21666690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
    Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
    Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
    Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
    Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKT TCR recognition of CD1d-α-C-galactosylceramide.
    Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
    J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
    Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
    J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.
    Li Y; Girardi E; Wang J; Yu ED; Painter GF; Kronenberg M; Zajonc DM
    J Exp Med; 2010 Oct; 207(11):2383-93. PubMed ID: 20921281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
    Gumperz JE
    Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
    Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
    J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
    Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
    Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.
    Florence WC; Xia C; Gordy LE; Chen W; Zhang Y; Scott-Browne J; Kinjo Y; Yu KO; Keshipeddy S; Pellicci DG; Patel O; Kjer-Nielsen L; McCluskey J; Godfrey DI; Rossjohn J; Richardson SK; Porcelli SA; Howell AR; Hayakawa K; Gapin L; Zajonc DM; Wang PG; Joyce S
    EMBO J; 2009 Nov; 28(22):3579-90. PubMed ID: 19816402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of canine natural CD3-positive T cells expressing an invariant T-cell receptor alpha chain.
    Yasuda N; Masuda K; Tsukui T; Teng A; Ishii Y
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):224-31. PubMed ID: 19748683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs.
    Tatituri RV; Watts GF; Bhowruth V; Barton N; Rothchild A; Hsu FF; Almeida CF; Cox LR; Eggeling L; Cardell S; Rossjohn J; Godfrey DI; Behar SM; Besra GS; Brenner MB; Brigl M
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1827-32. PubMed ID: 23307809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
    Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
    Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
    Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
    J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
    López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
    PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.